Published on in Vol 6, No 3 (2017): March

Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment for Patients With Metastatic Colorectal Cancer

Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment for Patients With Metastatic Colorectal Cancer

Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment for Patients With Metastatic Colorectal Cancer

Pradeep S Virdee   1 , BSc, MSc ;   Joanna Moschandreas   1 , BSc, MSc, PhD ;   Val Gebski   2 , MStat ;   Sharon B Love   1 , BSc ;   E Anne Francis   3 , BSc, D. Phil ;   Harpreet S Wasan   4 , MBBS, FRCP ;   Guy van Hazel   5 , MBBS, FRACP, FRCP ;   Peter Gibbs   6 , MBBS, FRACP, MD ;   Ricky A Sharma   7, 8 , MD, PhD

1 Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom

2 NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia

3 Oncology Clinical Trials Office, Department of Oncology, University of Oxford, Oxford, United Kingdom

4 Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom

5 University of Western Australia, Perth, Australia

6 Western Hospital, Footscray, Victoria, Australia

7 National Institute for Health Research University College London Hospitals Biomedical Research Centre, London, United Kingdom

8 Cancer Research United Kingdom–Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom

Corresponding Author:

  • Ricky A Sharma, MD, PhD
  • National Institute for Health Research University College London Hospitals Biomedical Research Centre
  • UCL Cancer Institute
  • University College London
  • London
  • United Kingdom
  • Phone: 44 020 3108 2212
  • Fax: 44 020 7679 6817
  • Email: ricky.sharma@oncology.ox.ac.uk